Skip to Main Content
Table 2.

Odds ratios and 95% confidence intervals for risk of prostate cancer by quartile of adiponectin

Quartile of adiponectin
P
Q1Q2Q3Q4
Cases, % [(n)/total (N)] 24/73 (32) 26/73 (35) 13/74 (17) 12/73 (16)  
Adiponectin      
    Median (range), ng/mL 3.4 (0.9–5.3) 6.8 (5.3–8.7) 10.7 (8.7–13.7) 18.7 (13.7–43.2)  
Cases vs control subjects      
    Age adjusted 1.0 0.74 (0.28–1.94) 0.27 (0.11–0.67) 0.31 (0.13–0.77) <0.01 
    Age and BMI adjusted 1.0 0.70 (0.27–1.86) 0.27 (0.11–0.67) 0.29 (0.12–0.73) <0.01 
    Multivariate* adjusted 1.0 0.60 (0.21–1.71) 0.27 (0.10–0.72) 0.29 (0.10–0.82) 0.03 
BPH vs control subjects      
    Age adjusted 1.0 0.76 (0.34–1.70) 0.60 (0.25–1.39) 0.55 (0.23–1.28) 0.65 
    Age and BMI adjusted 1.0 0.60 (0.26–1.41) 0.58 (0.25–1.37) 0.73 (0.33–1.62) 0.62 
    Multivariate* adjusted 1.0 0.52 (0.20–1.34) 0.49 (0.19–1.22) 0.64 (0.27–1.50) 0.47 
Quartile of adiponectin
P
Q1Q2Q3Q4
Cases, % [(n)/total (N)] 24/73 (32) 26/73 (35) 13/74 (17) 12/73 (16)  
Adiponectin      
    Median (range), ng/mL 3.4 (0.9–5.3) 6.8 (5.3–8.7) 10.7 (8.7–13.7) 18.7 (13.7–43.2)  
Cases vs control subjects      
    Age adjusted 1.0 0.74 (0.28–1.94) 0.27 (0.11–0.67) 0.31 (0.13–0.77) <0.01 
    Age and BMI adjusted 1.0 0.70 (0.27–1.86) 0.27 (0.11–0.67) 0.29 (0.12–0.73) <0.01 
    Multivariate* adjusted 1.0 0.60 (0.21–1.71) 0.27 (0.10–0.72) 0.29 (0.10–0.82) 0.03 
BPH vs control subjects      
    Age adjusted 1.0 0.76 (0.34–1.70) 0.60 (0.25–1.39) 0.55 (0.23–1.28) 0.65 
    Age and BMI adjusted 1.0 0.60 (0.26–1.41) 0.58 (0.25–1.37) 0.73 (0.33–1.62) 0.62 
    Multivariate* adjusted 1.0 0.52 (0.20–1.34) 0.49 (0.19–1.22) 0.64 (0.27–1.50) 0.47 
*

Multivariate model included age, BMI, smoking status, alcohol use, insulin level, and testosterone.

Close Modal

or Create an Account

Close Modal
Close Modal